Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Dustin Boothe"'
Autor:
Maria Sellitto, Guoyun Bai, Gloria Serena, W Florian Fricke, Craig Sturgeon, Pawel Gajer, James R White, Sara S K Koenig, Joyce Sakamoto, Dustin Boothe, Rachel Gicquelais, Deborah Kryszak, Elaine Puppa, Carlo Catassi, Jacques Ravel, Alessio Fasano
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e33387 (2012)
Celiac disease (CD) is a unique autoimmune disorder in which the genetic factors (DQ2/DQ8) and the environmental trigger (gluten) are known and necessary but not sufficient for its development. Other environmental components contributing to CD are po
Externí odkaz:
https://doaj.org/article/095af8d052d04096b09b4a1fb8a76b78
Autor:
Dustin Boothe, Samual Francis, David K. Gaffney, Theresa L. Werner, Michael B. Christensen, Aaron H. Wolfson
Publikováno v:
American Journal of Clinical Oncology. 42:549-554
OBJECTIVES Lymphovascular space invasion (LVSI) is a known prognostic factor for endometrial carcinomas. However, LVSI as a determinant of treatment benefit has not been fully elucidated. METHODS AND MATERIALS Data from the National Cancer Database f
Publikováno v:
Journal of Radiation Oncology. 8:63-72
Parotid tumors are rare, and no clinical trial data exists to guide postoperative radiation therapy (PORT) usage. We sought to determine the impact of PORT on the overall survival (OS) of patients with parotid malignancies. Patient data was queried f
Autor:
Andrew Orton, Theresa L. Werner, David K. Gaffney, Matthew M. Poppe, Dustin Boothe, Jaewhan Kim
Publikováno v:
American journal of clinical oncology. 42(11)
In endometrial cancer, the appropriate sequence of adjuvant chemotherapy (aCT) and adjuvant radiation therapy (aRT) is unclear. We aim evaluated whether early chemotherapy is associated with improved overall survival (OS) and cancer-specific survival
Publikováno v:
Journal of Radiation Oncology. 7:223-232
Radiation therapy (RT) may work synergistically with cancer immunotherapies but clinical trial data is needed to validate this paradigm. We isolated the portfolio of trials that investigate the primary immunomodulatory properties of RT and examined r
Autor:
Dustin Boothe, Ying J. Hitchcock, Hailey M. Shepherd, Jason P. Hunt, Jeffrey J. Houlton, John R. Weis, Richard B. Cannon, Marcus M. Monroe, Patrick S. Carpenter, Luke O. Buchmann, Shane Lloyd
Publikováno v:
Otolaryngology–Head and Neck Surgery. 159:473-483
Objectives To investigate clinicopathologic and treatment factors associated with survival in adult head and neck sarcomas in the National Cancer Database (NCDB). To analyze whether treatment settings and therapies received influence survival outcome
Autor:
Courtney L. Scaife, Molly E. Gross, Thomas Bartley Pickron, Dustin Boothe, Shane Lloyd, Alex Coffman, Jonathan Frandsen
Publikováno v:
Journal of Radiation Oncology. 7:213-222
We investigated the effect of neoadjuvant versus adjuvant chemoradiotherapy on overall survival as well as the impact of demographic and clinical factors for the selection of each approach utilizing the National Cancer Data Base. Adult patients with
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:819-824
The goal of this study was to assess the survival differences seen in early-stage and advanced-stage nodular lymphocytic predominant Hodgkin lymphoma (NLPHL) based on treatment modality.The National Cancer Database was queried to identify patients di
Autor:
Mark A. Lewis, Randa Tao, George Cannon, Dustin Boothe, Jonathan Whisenant, Robin D. Kim, Anna Torgeson, Ignacio Garrido-Laguna, Courtney L. Scaife, Shane Lloyd
Publikováno v:
Annals of Surgical Oncology. 24:4001-4008
Unresected extrahepatic cholangiocarcinoma (uEHCC) remains a deadly disease. Guidelines for uEHCC recommend either chemotherapy alone (CT) or chemoradiotherapy (CRT). This study used the National Cancer Database (NCDB) to compare outcomes for patient
Autor:
Ignacio Garrido-Laguna, George Cannon, Dustin Boothe, Anna Torgeson, Shane Lloyd, Randa Tao, Jonathan Whisenant
Publikováno v:
Cancer. 123:3816-3824
BACKGROUND The role of chemoradiotherapy (CRT) in locally advanced pancreatic cancer (LAPC) is uncertain after multiple randomized clinical trials have yielded mixed results. The authors used the National Cancer Data Base (NCDB) to determine whether